Management of small-cell cancer of the lung
- PMID: 1347865
- DOI: 10.1016/0140-6736(92)90287-d
Management of small-cell cancer of the lung
Comment in
-
Treatment of small cell carcinoma of the lung.Lancet. 1992 Jun 13;339(8807):1476-7. doi: 10.1016/0140-6736(92)92065-n. Lancet. 1992. PMID: 1351143 No abstract available.
Similar articles
-
Small cell lung cancer.Acta Oncol. 1989;28(5):729-41. doi: 10.3109/02841868909092304. Acta Oncol. 1989. PMID: 2556169 Review. No abstract available.
-
Practice guidelines for small cell lung cancer.Cancer J Sci Am. 1996 May-Jun;2(3A Suppl):S69-75. Cancer J Sci Am. 1996. PMID: 9166526 No abstract available.
-
The management of small cell lung cancer.N Z Med J. 1986 Feb 26;99(796):104-6. N Z Med J. 1986. PMID: 3005933 No abstract available.
-
Small-cell lung cancer: a curable disease?Br J Dis Chest. 1979 Oct;73(4):327-48. Br J Dis Chest. 1979. PMID: 233419 Review. No abstract available.
-
NCCN: Small cell lung cancer.Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):32-43. Cancer Control. 2001. PMID: 11760556 Review. No abstract available.
Cited by
-
Treatment Sequencing Strategies in Lung Cancer.Zhongguo Fei Ai Za Zhi. 2022 May 20;25(5):323-336. doi: 10.3779/j.issn.1009-3419.2022.104.01. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35599008 Free PMC article.
-
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.Br J Cancer. 2004 Aug 16;91(4):659-65. doi: 10.1038/sj.bjc.6602056. Br J Cancer. 2004. PMID: 15280919 Free PMC article. Clinical Trial.
-
P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.Br J Cancer. 1996 Dec;74(12):1929-34. doi: 10.1038/bjc.1996.655. Br J Cancer. 1996. PMID: 8980392 Free PMC article.
-
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.Br J Cancer. 1996 Jun;73(12):1569-75. doi: 10.1038/bjc.1996.296. Br J Cancer. 1996. PMID: 8664132 Free PMC article.
-
Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.BMC Cancer. 2024 Oct 1;24(1):1218. doi: 10.1186/s12885-024-12935-x. BMC Cancer. 2024. PMID: 39354432 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical